These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
205 related articles for article (PubMed ID: 34212982)
1. Interference with KCNJ2 inhibits proliferation, migration and EMT progression of apillary thyroid carcinoma cells by upregulating GNG2 expression. Chen S; Huang M; Hu X Mol Med Rep; 2021 Sep; 24(3):. PubMed ID: 34212982 [TBL] [Abstract][Full Text] [Related]
2. LncRNA SNHG12 promotes the proliferation and metastasis of papillary thyroid carcinoma cells through regulating wnt/β-catenin signaling pathway. Ding S; Qu W; Jiao Y; Zhang J; Zhang C; Dang S Cancer Biomark; 2018; 22(2):217-226. PubMed ID: 29630517 [TBL] [Abstract][Full Text] [Related]
3. [Knockdown of long non-coding RNA actin filament-associated protein 1 antisense RNA1 (AFAP1-AS1) inhibits epithelial-mesenchymal transition, invasion and migration of TPC-1 papillary thyroid cancer cells]. Fan H; Dong Q; Yu J; Yin L; Sun X; Yang X; Zhang W Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2021 Jan; 37(1):54-60. PubMed ID: 33441229 [TBL] [Abstract][Full Text] [Related]
4. MiR-577 inhibits papillary thyroid carcinoma cell proliferation, migration and invasion by targeting SphK2. Xue KC; Hu DD; Zhao L; Li N; Shen HY Eur Rev Med Pharmacol Sci; 2017 Oct; 21(17):3794-3800. PubMed ID: 28975989 [TBL] [Abstract][Full Text] [Related]
5. miR-214 regulates papillary thyroid carcinoma cell proliferation and metastasis by targeting PSMD10. Liu F; Lou K; Zhao X; Zhang J; Chen W; Qian Y; Zhao Y; Zhu Y; Zhang Y Int J Mol Med; 2018 Dec; 42(6):3027-3036. PubMed ID: 30272290 [TBL] [Abstract][Full Text] [Related]
6. LncRNA PROX1-AS1 promotes proliferation, invasion, and migration in papillary thyroid carcinoma. Shen Y; Xia E; Bhandari A; Wang X; Guo G Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30061172 [TBL] [Abstract][Full Text] [Related]
7. ABCG2/BCRP gene expression is related to epithelial-mesenchymal transition inducer genes in a papillary thyroid carcinoma cell line (TPC-1). Mato E; González C; Moral A; Pérez JI; Bell O; Lerma E; de Leiva A J Mol Endocrinol; 2014 Jun; 52(3):289-300. PubMed ID: 24643400 [TBL] [Abstract][Full Text] [Related]
8. MicroRNA-1266 suppresses papillary thyroid carcinoma cell metastasis and growth via targeting FGFR2. Fu YT; Zheng HB; Zhang DQ; Zhou L; Sun H Eur Rev Med Pharmacol Sci; 2018 Jun; 22(11):3430-3438. PubMed ID: 29917195 [TBL] [Abstract][Full Text] [Related]
9. Silencing long non-coding RNAs nicotinamide nucleotide transhydrogenase antisense RNA 1 inhibited papillary thyroid cancer cell proliferation, migration and invasion and promoted apoptosis via targeting miR-199a-5p. Wang D; Zheng Y Endocr J; 2021 May; 68(5):583-597. PubMed ID: 33612561 [TBL] [Abstract][Full Text] [Related]
10. MicroRNA-663 suppresses cell invasion and migration by targeting transforming growth factor beta 1 in papillary thyroid carcinoma. Wang Z; Zhang H; Zhang P; Dong W; He L Tumour Biol; 2016 Jun; 37(6):7633-44. PubMed ID: 26687649 [TBL] [Abstract][Full Text] [Related]
11. N-cadherin promotes thyroid tumorigenesis through modulating major signaling pathways. Da C; Wu K; Yue C; Bai P; Wang R; Wang G; Zhao M; Lv Y; Hou P Oncotarget; 2017 Jan; 8(5):8131-8142. PubMed ID: 28042956 [TBL] [Abstract][Full Text] [Related]
12. Growth-associated protein 43 promotes thyroid cancer cell lines progression via epithelial-mesenchymal transition. Zheng C; Quan RD; Wu CY; Hu J; Lin BY; Dong XB; Xia EJ; Bhandari A; Zhang XH; Wang OC J Cell Mol Med; 2019 Dec; 23(12):7974-7984. PubMed ID: 31568662 [TBL] [Abstract][Full Text] [Related]
13. MicroRNA-1271 inhibits the progression of papillary thyroid carcinoma by targeting IRS1 and inactivating AKT pathway. Chen Y; Hao SA; Jiang Y; Gao B; Tian WG; Zhang S; Guo LJ; Wang LL; Luo DL Eur Rev Med Pharmacol Sci; 2019 Sep; 23(18):7989-7999. PubMed ID: 31599424 [TBL] [Abstract][Full Text] [Related]
14. High expression of LINC0163 promotes progression of papillary thyroid cancer by regulating epithelial-mesenchymal transition MITF. Gao P; Jiao H; Zhe L; Cui J Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5504-5511. PubMed ID: 32495885 [TBL] [Abstract][Full Text] [Related]
15. Chen CZ; Wen JL; Lin BY; Zheng C; Quan RD; Zhang XH; Qu JM Biomark Med; 2020 Jul; 14(11):969-980. PubMed ID: 32940082 [No Abstract] [Full Text] [Related]
16. KCNIP3 silence promotes proliferation and epithelial-mesenchymal transition of papillary thyroid carcinoma through activating Wnt/β-catenin pathway. Zhong J; Lin R; Wang G; Lin L; Ruan S; Liu W Tissue Cell; 2022 Apr; 75():101739. PubMed ID: 35066335 [TBL] [Abstract][Full Text] [Related]
17. microRNA-539 functions as a tumor suppressor in papillary thyroid carcinoma via the transforming growth factor β1/Smads signaling pathway by targeting secretory leukocyte protease inhibitor. Xu CB; Liu XS; Li JQ; Zhao X; Xin D; Yu D J Cell Biochem; 2019 Jun; 120(6):10830-10846. PubMed ID: 30706537 [TBL] [Abstract][Full Text] [Related]
18. MiR-630 inhibits papillary thyroid carcinoma cell growth, metastasis, and epithelial-mesenchymal transition by suppressing JAK2/STAT3 signaling pathway. Pan XM; He XY; Yang YL; Jia WJ; Yang ZQ; Yan D; Ma JX Eur Rev Med Pharmacol Sci; 2019 Mar; 23(6):2453-2460. PubMed ID: 30964171 [TBL] [Abstract][Full Text] [Related]
19. Upregulation of the inwardly rectifying potassium channel Kir2.1 (KCNJ2) modulates multidrug resistance of small-cell lung cancer under the regulation of miR-7 and the Ras/MAPK pathway. Liu H; Huang J; Peng J; Wu X; Zhang Y; Zhu W; Guo L Mol Cancer; 2015 Mar; 14():59. PubMed ID: 25880778 [TBL] [Abstract][Full Text] [Related]
20. Mechanism of RET gene mediated EGFR signaling pathway on epithelial-mesenchymal transition, proliferation and apoptosis of papillary thyroid carcinoma cells. Zhao YL; Yuan BQ; Shen GS Eur Rev Med Pharmacol Sci; 2020 Aug; 24(15):8036-8047. PubMed ID: 32767330 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]